2361 related articles for article (PubMed ID: 33771638)
1. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
[TBL] [Abstract][Full Text] [Related]
2. Exploring the protective effect of ShengMai-Yin and Ganmaidazao decoction combination against type 2 diabetes mellitus with nonalcoholic fatty liver disease by network pharmacology and validation in KKAy mice.
Li S; Qian Y; Xie R; Li Y; Jia Z; Zhang Z; Huang R; Tuo L; Quan Y; Yu Z; Liu J; Xiang M
J Ethnopharmacol; 2019 Oct; 242():112029. PubMed ID: 31216433
[TBL] [Abstract][Full Text] [Related]
3. FTZ attenuates liver steatosis and fibrosis in the minipigs with type 2 diabetes by regulating the AMPK signaling pathway.
Wang H; Huang M; Bei W; Yang Y; Song L; Zhang D; Zhan W; Zhang Y; Chen X; Wang W; Wang L; Guo J
Biomed Pharmacother; 2021 Jun; 138():111532. PubMed ID: 34311531
[TBL] [Abstract][Full Text] [Related]
4. The traditional Chinese medicine formula Fufang-Zhenzhu-Tiaozhi protects myocardia from injury in diabetic minipigs with coronary heart disease.
Song L; Zhang D; Guo C; Gu Z; Wang L; Yao YS; Wang H; Zeng Z; Wang W; Yang Y; Bei W; Rong X; Guo J
Biomed Pharmacother; 2021 May; 137():111343. PubMed ID: 33761594
[TBL] [Abstract][Full Text] [Related]
5. Tangganjian decoction ameliorates type 2 diabetes mellitus and nonalcoholic fatty liver disease in rats by activating the IRS/PI3K/AKT signaling pathway.
Fan Y; He Z; Wang W; Li J; Hu A; Li L; Yan L; Li Z; Yin Q
Biomed Pharmacother; 2018 Oct; 106():733-737. PubMed ID: 29990865
[TBL] [Abstract][Full Text] [Related]
6. Alleviation of Fufang Fanshiliu decoction on type II diabetes mellitus by reducing insulin resistance: A comprehensive network prediction and experimental validation.
Dai W; Chen C; Dong G; Li G; Peng W; Liu X; Yang J; Li L; Xu R; Hu X
J Ethnopharmacol; 2022 Aug; 294():115338. PubMed ID: 35568115
[TBL] [Abstract][Full Text] [Related]
7. [Mechanism of Astragali Radix-Puerariae Lobatae Radix combination in regulating type 2 diabetes mellitus through AMPK signaling pathway: based on network pharmacology and experimental verification].
Wei S; Li J; Han DW; Fu Q; Hao F
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(10):2738-2749. PubMed ID: 35718494
[TBL] [Abstract][Full Text] [Related]
8. The effect of Liuwei Dihuang decoction on PI3K/Akt signaling pathway in liver of type 2 diabetes mellitus (T2DM) rats with insulin resistance.
Dai B; Wu Q; Zeng C; Zhang J; Cao L; Xiao Z; Yang M
J Ethnopharmacol; 2016 Nov; 192():382-389. PubMed ID: 27401286
[TBL] [Abstract][Full Text] [Related]
9. Scutellariae Radix and Coptidis Rhizoma Improve Glucose and Lipid Metabolism in T2DM Rats via Regulation of the Metabolic Profiling and MAPK/PI3K/Akt Signaling Pathway.
Cui X; Qian DW; Jiang S; Shang EX; Zhu ZH; Duan JA
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453687
[No Abstract] [Full Text] [Related]
10. Liver Lipidomics Analysis Revealed the Protective mechanism of Zuogui Jiangtang Qinggan Formula in type 2 diabetes mellitus with non-alcoholic fatty liver disease.
Zhou M; Liu X; Wu Y; Xiang Q; Yu R
J Ethnopharmacol; 2024 Jul; 329():118160. PubMed ID: 38588985
[TBL] [Abstract][Full Text] [Related]
11. Network pharmacology combined with molecular docking and experimental verification to elucidate functional mechanism of Fufang Zhenzhu Tiaozhi against type 2 diabetes mellitus.
Li B; Li X; Zeng Y; Zhou Z; Zhao D; Qin F; Zhang B; Yao W; Mao Y; Zhou L; Li K; Zhu Q; Rong X; Guo J
J Biomol Struct Dyn; 2023 Nov; ():1-17. PubMed ID: 37942992
[TBL] [Abstract][Full Text] [Related]
12. The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against renal injury and inflammation in mice with diabetic kidney disease.
Yang YQ; Tan HB; Zhang XY; Zhang YZ; Lin QY; Huang MY; Lin ZY; Mo JZ; Zhang Y; Lan T; Bei WJ; Guo J
J Ethnopharmacol; 2022 Jun; 292():115165. PubMed ID: 35247475
[TBL] [Abstract][Full Text] [Related]
13. Study on the action mechanism of the Polygonum perfoliatum L. on non-alcoholic fatty liver disease, based on network pharmacology and experimental validation.
Liu G; Yang L; Tang Y; Lin J; Wang F; Shen J; Chang B; Kong X
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117330. PubMed ID: 37863399
[TBL] [Abstract][Full Text] [Related]
14. Exploring therapeutic mechanisms of San-Huang-Tang in nonalcoholic fatty liver disease through network pharmacology and experimental validation.
Shi H; Qiao F; Huang K; Lu W; Zhang X; Ke Z; Wu Y; Cao L; Chen Y
J Ethnopharmacol; 2022 Oct; 296():115477. PubMed ID: 35764198
[TBL] [Abstract][Full Text] [Related]
15. Ellagic Acid Alleviates Hepatic Oxidative Stress and Insulin Resistance in Diabetic Female Rats.
Polce SA; Burke C; França LM; Kramer B; de Andrade Paes AM; Carrillo-Sepulveda MA
Nutrients; 2018 Apr; 10(5):. PubMed ID: 29693586
[TBL] [Abstract][Full Text] [Related]
16. Exploring Anti-Type 2 Diabetes Mellitus Mechanism of Gegen Qinlian Decoction by Network Pharmacology and Experimental Validation.
Bao W; Sun H; Wu X; Xu J; Zhang H; Cao L; Fan Y
Dis Markers; 2022; 2022():1927688. PubMed ID: 36284987
[TBL] [Abstract][Full Text] [Related]
17. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
Zhang J; Du H; Shen M; Zhao Z; Ye X
J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
[TBL] [Abstract][Full Text] [Related]
18. Anti-hyperglycemic and anti-hyperlipidemic effects of a special fraction of Luohanguo extract on obese T2DM rats.
Zhang Y; Zhou G; Peng Y; Wang M; Li X
J Ethnopharmacol; 2020 Jan; 247():112273. PubMed ID: 31586692
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology, molecular docking and molecular dynamics simulation.
Yang R; Yang H; Jiang D; Xu L; Feng L; Xing Y
PeerJ; 2022; 10():e14171. PubMed ID: 36389420
[TBL] [Abstract][Full Text] [Related]
20. The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against atherosclerosis by suppressing EndMT via modulating Akt1/β-catenin signaling pathway.
Diao H; Cheng J; Huang X; Huang B; Shao X; Zhao J; Lan D; Zhu Q; Yan M; Zhang Y; Rong X; Guo J
J Ethnopharmacol; 2022 Jul; 293():115261. PubMed ID: 35447198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]